Experience using a proprietary femtosecond laser with an integrated, real-time optical coherence tomography imaging device highlights the advantages provided by this technology in performing cataract surgery and its potential to raise the bar for functional and safety outcomes.
Based on available evidence, intracameral cefuroxime represents the best, safest, and most effective antimicrobial agent to use for prophylaxis of postcataract surgery endophthalmitis.
Has the time come for a widespread adoption of telemedicine screening for retinopathy of prematurity?
Ketorolac tromethamine ophthalmic solution 0.45%, a third-generation formulation of the nonsteroidal anti-inflammatory drug, had a highly beneficial effect on visual acuity after cataract surgery in a recent study.
A post hoc analysis of data collected in two published, pivotal clinical trials demonstrates that in addition to its efficacy for treating inflammation following ocular surgery, loteprednol etabonate ophthalmic suspension 0.5% provides statistically significant relief of postoperative pain and other symptoms.
In a quantitative determination of the prophylactic effectiveness of two commercially available ocular fluoroquiinolones within the anterior chamber of rabbit eyes, moxifloxacin ophthalmic solution 0.5% demonstrated significantly greater bacterial killing than besifloxacin ophthalmic suspension 0.6%.
A broad-spectrum macrolide antibiotic also may have anti-inflammatory properties.
The availability of a new formulation of gatifloxacin ophthalmic solution containing 0.5% active ingredient will provide ophthalmologists with a valuable option for addressing the growing problem of resistance among some important ocular pathogens.
In a study performed to evaluate and compare preserved versus unpreserved fluoroquinolone antibiotics, cell culture assays demonstrated some degree of toxicity and elevated induction of apoptosis in each of three commercially available topical ocular fluoroquinolone antibiotics.
Understand exchange-traded funds and why you may want one.
Has the time come for a widespread adoption of telemedicine screening for retinopathy of prematurity?
Data from 1 year of follow-up in a 2-year study demonstrate a favorable clinical performance of a microincisional IOL designed for implantation through a 1.8 mm incision.
Fibrin glue-assisted posterior IOL implantation is a beneficial technique for clinical indications such as dislocated nucleus, dislocated IOL, or subluxated cataract.
Results of a study comparing 1- and 3-piece models of the anterior surface modified prolate hydrophobic acrylic IOL show excellent capsule bag performance of both implants.
The +3.0-D add version of the apodized diffractive multifocal IOL provides a high rate of spectacle independence.
Results of retrospective analyses refute an association between relative humidity in the operating room and LASIK refractive outcomes.
After years of wrangling in court with two former regional manufacturer's representatives, officials at STAAR Surgical Co. hope a $4 million settlement will allow it to move forward with new products and solidify its financial status.
LenSx Lasers Inc. announced it received FDA clearance of its proprietary femtosecond laser technology for use in performing phacofragmentation during cataract surgery.
The American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery are among 25 groups urging Congress to solve the Medicare physician payment problem.
It's important to understand this simple phrase: Pediatrics is different.
Proper specialized instrumentation and a dispersive ophthalmic viscosurgical device are integral to the success of explantation and exchange of multifocal IOLs.
Advances in technology have changed the way we do business greatly.
J&J Vision Care may continue selling its Acuvue Oasys contact lenses even though their manufacturing infringes CIBA Vision's patent, in order to protect "millions of innocent contact lens wearers" who would have to be refitted with a different brand, a federal judge has ruled.
Concern about potential long-term toxicity associated with use of mitomycin-C is driving researchers to identify new pharmacologic approaches for managing haze formation after PRK.
Analyses of 24-month data from the two pivotal phase III trials investigating a proprietary fluocinolone acetonide-releasing intravitreal insert for the treatment of diabetic macular edema generated positive results that are the basis of filing a new drug application with the FDA.
.png "Optometry Times"){kind=logo}
